Leneva
Leneva is a first-of-its-kind human adipose tissue for soft tissue reconstruction.
As an all-natural extracellular injectable matrix, Leneva is a safe, natural, off-the-shelf solution that has multiple clinical applications including, but not limited to:
• Diabetic Foot Ulcers
• Pressure Ulcers
• Tunneling Wounds
• Fat Pad Reconstruction Procedures
Key Features:
- Ready to use out of packaging reducing procedural preparation time
- Wound treatment may allow for decreased long-term health costs from repeat patient visits due to wound recurrence
- Preservation of natural derived endogenous components (matrix proteins, growth factors, cytokines) vital to adipogenesis and angiogenesis
- Provides extracellular matrix that functions as a scaffold for patients own cells to create new fat
- Pre-clinical studies in athymic mice demonstrate significant adipocyte formation in the host
- Leneva is tested for sterility per USP<71> without the need for terminal sterilization methods
- Faster Healing: Meshed design facilitates fluid drainage and encourages cellular ingrowth, promoting quicker integration and healing.
- Enhanced Flexibility: Its pliable structure conforms easily to complex anatomical areas, providing better wound coverage.
- Reduced Risk of Infection: Aseptic processing and acellular properties minimize immune rejection and infection risks.
- Durability and Strength: Designed to withstand handling and support healing in complex wounds, including diabetic ulcers and surgical sites.
- Ready-to-Use: Prehydrated for immediate application, simplifying the process for healthcare providers
OUR TEAM
Behind our innovative wound care solutions is a dedicated team, passionate about advancing healing and enhancing patient outcomes. Committed to excellence, we work hand-in-hand with clinicians to deliver superior care.
ANTHONY KIRCHNER
Founder & Ceo
DOMINIQUE ARANGO
Midwest Sales Manager
MIRLENE DENOYE
Director of Sales
JOHN GARRETTSON
Chief Strategy Officer
